Yi Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yi Li has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Dongrui Zhang
Department of Respiratory and Critical Care Medicine, Tianjin Chest Hospital, Tianjin, China
1 shared publicationFang Lu
Department of Respiratory and Critical Care Medicine, Tianjin Chest Hospital, Tianjin, China
1 shared publicationGuanhua Li
Department of Respiratory and Critical Care Medicine, Tianjin Chest Hospital, Tianjin, China
1 shared publicationHongyu Qian
Department of Respiratory and Critical Care Medicine, Tianjin Chest Hospital, Tianjin, People's Republic of China
1 shared publication- Jau-Shyong Hong
Neurobiology Laboratory, NIH/NIEHS, Research Triangle Park, NC, USA
1 shared publication - Jing Feng
Department of Respiratory and Critical Care Medicine, Tianjin Medical University General Hospital, Tianjin, China
1 shared publication
Latest Publications
- Open Access
- 17 December 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1619612
Case Report: Rare pleural effusion—a case of B-lymphoblastic lymphoma presenting with pleural effusion and diagnostic challenges
Background: Lymphoblastic lymphoma is a rare type of malignant lymphoma. B-lymphoblastic lymphoma with pleural effusion as the initial manifestation is extremely rare; in this study, we report a specific and challenging diagnostic process. Case presentation: We present the case of a 67-year-old woman who was initially diagnosed with tuberculous pleurisy with a right pleural effusion. The pleural effusion was an exudate composed primarily of mononuclear cells with elevated adenosine deaminase (ADA) and lactate dehydrogenase (LDH). The cytological results of the pleural effusion were negative. The contrast-enhanced CT suggested right pleural nodules with partial pleural thickening. Subsequently, a CT-guided percutaneous needle pleural biopsy was performed, and pathological consultation, bone marrow biopsy, and flow cytology examination were carried out. Finally, B-lymphoblastic lymphoma was diagnosed. During a recent follow-up, the patient showed signs of improvement nearly without pleural effusion after chemotherapy. Conclusion: Malignant pleural effusion caused by lymphoma can be easily misdiagnosed as tuberculous pleurisy, as both conditions commonly show markedly elevated levels of ADA and LDH. Flow cytology examination of pleural fluid can be considered, and histological specimens should be actively obtained to clarify the pathological diagnosis. For patients with extensive pleural thickening, a CT-guided percutaneous pleural biopsy can be preferentially selected.
- 17 December 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1619612
Open AccessCase Report: Rare pleural effusion—a case of B-lymphoblastic lymphoma presenting with pleural effusion and diagnostic challenges
Background: Lymphoblastic lymphoma is a rare type of malignant lymphoma. B-lymphoblastic lymphoma with pleural effusion as the initial manifestation is extremely rare; in this study, we report a specific and challenging diagnostic process. Case presentation: We present the case of a 67-year-old woman who was initially diagnosed with tuberculous pleurisy with a right pleural effusion. The pleural effusion was an exudate composed primarily of mononuclear cells with elevated adenosine deaminase (ADA) and lactate dehydrogenase (LDH). The cytological results of the pleural effusion were negative. The contrast-enhanced CT suggested right pleural nodules with partial pleural thickening. Subsequently, a CT-guided percutaneous needle pleural biopsy was performed, and pathological consultation, bone marrow biopsy, and flow cytology examination were carried out. Finally, B-lymphoblastic lymphoma was diagnosed. During a recent follow-up, the patient showed signs of improvement nearly without pleural effusion after chemotherapy. Conclusion: Malignant pleural effusion caused by lymphoma can be easily misdiagnosed as tuberculous pleurisy, as both conditions commonly show markedly elevated levels of ADA and LDH. Flow cytology examination of pleural fluid can be considered, and histological specimens should be actively obtained to clarify the pathological diagnosis. For patients with extensive pleural thickening, a CT-guided percutaneous pleural biopsy can be preferentially selected.
- Open Access
- 1 May 2022
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 10 (10) , 583
G9a promotes inflammation in Streptococcus pneumoniae induced pneumonia mice by stimulating M1 macrophage polarization and H3K9me2 methylation in FOXP1 promoter region
Original Article G9a promotes inflammation in Streptococcus pneumoniae induced pneumonia mice by stimulating M1 macrophage polarization and H3K9me2 methylation in FOXP1 promoter region Yi Li, Guanhua Li, Li Zhang, Yuechuan Li, Zhan Zhao
- 1 May 2022
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 10 (10) , 583
Open AccessG9a promotes inflammation in Streptococcus pneumoniae induced pneumonia mice by stimulating M1 macrophage polarization and H3K9me2 methylation in FOXP1 promoter region
Original Article G9a promotes inflammation in Streptococcus pneumoniae induced pneumonia mice by stimulating M1 macrophage polarization and H3K9me2 methylation in FOXP1 promoter region Yi Li, Guanhua Li, Li Zhang, Yuechuan Li, Zhan Zhao
- Open Access
- 1 May 2022
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 17, 1131-1142
The Long-Term Maintenance Effect of Remote Pulmonary Rehabilitation via Social Media in COPD: A Randomized Controlled Trial
Background: Although the benefits of conventional pulmonary rehabilitation (PR) maintenance are well documented, it is challenged by many difficulties. We investigated whether remote home-based PR maintenance strategy via social media (WeChat) is effective on clinical improvements and reducing the risk for acute exacerbation of chronic obstructive pulmonary disease (COPD). Methods: The eligible stable COPD patients completing an initial 8-week PR were allocated into three groups randomly. Group A: PR maintenance via social media supervision at home. Group B: PR maintenance at hospital. Group C: Usual care. During a 12-month follow-up, the frequency of acute exacerbation of COPD (AECOPD), 6 minutes walking test (6MWT), COPD assessment test (CAT), and modified Medical Research Council scale (mMRC) were evaluated every 3 months. Results: At the end of the follow-up, compared to the decline in the usual care group (n = 49), the clinical improvements of 6MWD, CAT, and mMRC were sustained in both the home-based group (n = 47) and the hospital-based maintenance group (n = 44) (p < 0.001), no difference was observed between these two groups (p > 0.05). In multivariate analysis, the home-based PR maintenance and hospital-based PR maintenance were independent predictors of lower risk for AECOPD (incidence rate ratio (IRR) 0.712, 95% CI 0.595– 0.841, p < 0.001 and IRR 0.799, 95% CI 0.683– 0.927, p = 0.002), respectively. Conclusion: Remote PR maintenance via social media is effective in reducing the risk for AECOPD and keeping the clinical improvement from decline. Remote PR maintenance via social media might be used to deliver alternatives to conventional PR.
- 1 May 2022
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 17, 1131-1142
Open AccessThe Long-Term Maintenance Effect of Remote Pulmonary Rehabilitation via Social Media in COPD: A Randomized Controlled Trial
Background: Although the benefits of conventional pulmonary rehabilitation (PR) maintenance are well documented, it is challenged by many difficulties. We investigated whether remote home-based PR maintenance strategy via social media (WeChat) is effective on clinical improvements and reducing the risk for acute exacerbation of chronic obstructive pulmonary disease (COPD). Methods: The eligible stable COPD patients completing an initial 8-week PR were allocated into three groups randomly. Group A: PR maintenance via social media supervision at home. Group B: PR maintenance at hospital. Group C: Usual care. During a 12-month follow-up, the frequency of acute exacerbation of COPD (AECOPD), 6 minutes walking test (6MWT), COPD assessment test (CAT), and modified Medical Research Council scale (mMRC) were evaluated every 3 months. Results: At the end of the follow-up, compared to the decline in the usual care group (n = 49), the clinical improvements of 6MWD, CAT, and mMRC were sustained in both the home-based group (n = 47) and the hospital-based maintenance group (n = 44) (p < 0.001), no difference was observed between these two groups (p > 0.05). In multivariate analysis, the home-based PR maintenance and hospital-based PR maintenance were independent predictors of lower risk for AECOPD (incidence rate ratio (IRR) 0.712, 95% CI 0.595– 0.841, p < 0.001 and IRR 0.799, 95% CI 0.683– 0.927, p = 0.002), respectively. Conclusion: Remote PR maintenance via social media is effective in reducing the risk for AECOPD and keeping the clinical improvement from decline. Remote PR maintenance via social media might be used to deliver alternatives to conventional PR.
- Open Access
Early-Released Interleukin-10 Significantly Inhibits Lipopolysaccharide-Elicited Neuroinflammation In Vitro
Anti-inflammatory cytokine interleukin (IL)-10 is pivotal for limiting excessive inflammation in the central nervous system. Reports show that lipopolysaccharide (LPS)-induced microglial IL-10 emerges in a delayed manner in vitro and in vivo, lagging behind proinflammatory cytokines to facilitate the resolution of neuroinflammation. We hypothesized that IL-10 releases quite quickly based on our pilot investigation. Here, we uncovered a bimodal expression of microglial IL-10 gene transcription induced by LPS in mouse primary mixed glial cultures. This pattern consisted of a short brief early-phase and a long-lived late-phase, enabling the production of IL-10 protein in a rapid manner. The removal and addition of IL-10 protein assays indicated that early-released IL-10 exerted potent modulatory effects on neuroinflammation at picomolar levels, and IL-10 released at the onset of neuroinflammation is tightly controlled. We further showed that the early-released, but not the late-released, IL-10 was crucial for mediating and potentiating the anti-inflammatory function of a β2-adrenergic receptor agonist salmeterol. This study in vitro highlights the essential role of early-released IL-10 in regulating the appropriate degree of neuroinflammation, overturning the previous notion that microglial IL-10 produces and functions in a delayed manner and providing new insights into anti-inflammatory mechanisms-mediated neuroimmune homeostasis.
Open AccessEarly-Released Interleukin-10 Significantly Inhibits Lipopolysaccharide-Elicited Neuroinflammation In Vitro
Anti-inflammatory cytokine interleukin (IL)-10 is pivotal for limiting excessive inflammation in the central nervous system. Reports show that lipopolysaccharide (LPS)-induced microglial IL-10 emerges in a delayed manner in vitro and in vivo, lagging behind proinflammatory cytokines to facilitate the resolution of neuroinflammation. We hypothesized that IL-10 releases quite quickly based on our pilot investigation. Here, we uncovered a bimodal expression of microglial IL-10 gene transcription induced by LPS in mouse primary mixed glial cultures. This pattern consisted of a short brief early-phase and a long-lived late-phase, enabling the production of IL-10 protein in a rapid manner. The removal and addition of IL-10 protein assays indicated that early-released IL-10 exerted potent modulatory effects on neuroinflammation at picomolar levels, and IL-10 released at the onset of neuroinflammation is tightly controlled. We further showed that the early-released, but not the late-released, IL-10 was crucial for mediating and potentiating the anti-inflammatory function of a β2-adrenergic receptor agonist salmeterol. This study in vitro highlights the essential role of early-released IL-10 in regulating the appropriate degree of neuroinflammation, overturning the previous notion that microglial IL-10 produces and functions in a delayed manner and providing new insights into anti-inflammatory mechanisms-mediated neuroimmune homeostasis.